Experimental models for the study of prostatic adenocarcinoma

J. K. Smolev, D. S. Coffey, W. W. Scott

Research output: Contribution to journalArticle

Abstract

The Dunning R3327H transplantable rat tumor is a well differentiated prostatic adenocarcinoma. Its biologic properties have been characterized, and it appears that this animal model is well suited for studying prostatic cancer. The tumor responds to castration therapy, which is subsequently followed by a relapse to hormone insensitivity. Cell kinetic studies indicate that 70 to 90% of the total tumor cells are hormonally sensitive, and a subpopulation of 8 to 30% are hormone insensitive. The therapeutic relapse to androgen deprivation represents the continued growth of the cell clone, which was hormone insensitive. It appears that this animal tumor mimics the relapse phenomenon observed in the hormonal control of human prostatic cancer.

Original languageEnglish (US)
JournalJournal of Urology
Volume118
Issue number1
StatePublished - 1977

Fingerprint

Adenocarcinoma
Theoretical Models
Hormones
Recurrence
Neoplasms
Prostatic Neoplasms
Castration
Androgens
Animal Models
Clone Cells
Therapeutics
Growth

ASJC Scopus subject areas

  • Urology

Cite this

Smolev, J. K., Coffey, D. S., & Scott, W. W. (1977). Experimental models for the study of prostatic adenocarcinoma. Journal of Urology, 118(1).

Experimental models for the study of prostatic adenocarcinoma. / Smolev, J. K.; Coffey, D. S.; Scott, W. W.

In: Journal of Urology, Vol. 118, No. 1, 1977.

Research output: Contribution to journalArticle

Smolev, JK, Coffey, DS & Scott, WW 1977, 'Experimental models for the study of prostatic adenocarcinoma', Journal of Urology, vol. 118, no. 1.
Smolev, J. K. ; Coffey, D. S. ; Scott, W. W. / Experimental models for the study of prostatic adenocarcinoma. In: Journal of Urology. 1977 ; Vol. 118, No. 1.
@article{50cb7f72172c478384b4a8d142952360,
title = "Experimental models for the study of prostatic adenocarcinoma",
abstract = "The Dunning R3327H transplantable rat tumor is a well differentiated prostatic adenocarcinoma. Its biologic properties have been characterized, and it appears that this animal model is well suited for studying prostatic cancer. The tumor responds to castration therapy, which is subsequently followed by a relapse to hormone insensitivity. Cell kinetic studies indicate that 70 to 90{\%} of the total tumor cells are hormonally sensitive, and a subpopulation of 8 to 30{\%} are hormone insensitive. The therapeutic relapse to androgen deprivation represents the continued growth of the cell clone, which was hormone insensitive. It appears that this animal tumor mimics the relapse phenomenon observed in the hormonal control of human prostatic cancer.",
author = "Smolev, {J. K.} and Coffey, {D. S.} and Scott, {W. W.}",
year = "1977",
language = "English (US)",
volume = "118",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Experimental models for the study of prostatic adenocarcinoma

AU - Smolev, J. K.

AU - Coffey, D. S.

AU - Scott, W. W.

PY - 1977

Y1 - 1977

N2 - The Dunning R3327H transplantable rat tumor is a well differentiated prostatic adenocarcinoma. Its biologic properties have been characterized, and it appears that this animal model is well suited for studying prostatic cancer. The tumor responds to castration therapy, which is subsequently followed by a relapse to hormone insensitivity. Cell kinetic studies indicate that 70 to 90% of the total tumor cells are hormonally sensitive, and a subpopulation of 8 to 30% are hormone insensitive. The therapeutic relapse to androgen deprivation represents the continued growth of the cell clone, which was hormone insensitive. It appears that this animal tumor mimics the relapse phenomenon observed in the hormonal control of human prostatic cancer.

AB - The Dunning R3327H transplantable rat tumor is a well differentiated prostatic adenocarcinoma. Its biologic properties have been characterized, and it appears that this animal model is well suited for studying prostatic cancer. The tumor responds to castration therapy, which is subsequently followed by a relapse to hormone insensitivity. Cell kinetic studies indicate that 70 to 90% of the total tumor cells are hormonally sensitive, and a subpopulation of 8 to 30% are hormone insensitive. The therapeutic relapse to androgen deprivation represents the continued growth of the cell clone, which was hormone insensitive. It appears that this animal tumor mimics the relapse phenomenon observed in the hormonal control of human prostatic cancer.

UR - http://www.scopus.com/inward/record.url?scp=0017664747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017664747&partnerID=8YFLogxK

M3 - Article

C2 - 875219

AN - SCOPUS:0017664747

VL - 118

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 1

ER -